Correlation Between MERCK Kommanditgesells and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both MERCK Kommanditgesells and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MERCK Kommanditgesells and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MERCK Kommanditgesellschaft auf and Cannara Biotech, you can compare the effects of market volatilities on MERCK Kommanditgesells and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MERCK Kommanditgesells with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of MERCK Kommanditgesells and Cannara Biotech.
Diversification Opportunities for MERCK Kommanditgesells and Cannara Biotech
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between MERCK and Cannara is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding MERCK Kommanditgesellschaft au and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and MERCK Kommanditgesells is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MERCK Kommanditgesellschaft auf are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of MERCK Kommanditgesells i.e., MERCK Kommanditgesells and Cannara Biotech go up and down completely randomly.
Pair Corralation between MERCK Kommanditgesells and Cannara Biotech
Assuming the 90 days horizon MERCK Kommanditgesellschaft auf is expected to under-perform the Cannara Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, MERCK Kommanditgesellschaft auf is 4.02 times less risky than Cannara Biotech. The pink sheet trades about -0.23 of its potential returns per unit of risk. The Cannara Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 51.00 in Cannara Biotech on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Cannara Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MERCK Kommanditgesellschaft au vs. Cannara Biotech
Performance |
| Timeline |
| MERCK Kommanditgesells |
| Cannara Biotech |
MERCK Kommanditgesells and Cannara Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MERCK Kommanditgesells and Cannara Biotech
The main advantage of trading using opposite MERCK Kommanditgesells and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MERCK Kommanditgesells position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.| MERCK Kommanditgesells vs. Holloman Energy Corp | MERCK Kommanditgesells vs. cbdMD Inc | MERCK Kommanditgesells vs. Evolus Inc | MERCK Kommanditgesells vs. CV Sciences |
| Cannara Biotech vs. Holloman Energy Corp | Cannara Biotech vs. cbdMD Inc | Cannara Biotech vs. Evolus Inc | Cannara Biotech vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |